Aidan Irwin-Singer

711 total citations
9 papers, 296 citations indexed

About

Aidan Irwin-Singer is a scholar working on Infectious Diseases, Modeling and Simulation and Health. According to data from OpenAlex, Aidan Irwin-Singer has authored 9 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Modeling and Simulation and 2 papers in Health. Recurrent topics in Aidan Irwin-Singer's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (5 papers) and COVID-19 epidemiological studies (4 papers). Aidan Irwin-Singer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (5 papers) and COVID-19 epidemiological studies (4 papers). Aidan Irwin-Singer collaborates with scholars based in United Kingdom, Croatia and United States. Aidan Irwin-Singer's co-authors include Madhumita Shrotri, Maria Krutikov, Gokhan Tut, Laura Shallcross, Tom Palmer, Paul Moss, Andrew Copas, Andrew Hayward, Borscha Azmi and Christopher Fuller and has published in prestigious journals such as The Lancet Infectious Diseases, Eurosurveillance and Journal of the American Medical Directors Association.

In The Last Decade

Aidan Irwin-Singer

9 papers receiving 291 citations

Peers

Countries citing papers authored by Aidan Irwin-Singer

Since Specialization

Citations

This map shows the geographic impact of Aidan Irwin-Singer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aidan Irwin-Singer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aidan Irwin-Singer more than expected).

Fields of papers citing papers by Aidan Irwin-Singer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aidan Irwin-Singer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aidan Irwin-Singer. The network helps show where Aidan Irwin-Singer may publish in the future.

Co-authorship network of co-authors of Aidan Irwin-Singer

This figure shows the co-authorship network connecting the top 25 collaborators of Aidan Irwin-Singer. A scholar is included among the top collaborators of Aidan Irwin-Singer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aidan Irwin-Singer. Aidan Irwin-Singer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Built Environment and SARS-CoV-2 Transmission in Long-Term Care Facilities: Cross-Sectional Survey and Data Linkage 2023 ·Journal of the American Medical Directors Association ·Maria Krutikov, Oliver Stirrup, Chris Fuller, Natalie Adams, Borscha Azmi, Aidan Irwin-Singer, (unknown), Andrew Hayward, (unknown), Andrew Copas, Laura Shallcross	2
2	Clinical Effectiveness of SARS-CoV-2 Booster Vaccine Against Omicron Infection in Residents and Staff of Long-term Care Facilities: A Prospective Cohort Study (VIVALDI) 2022 ·Open Forum Infectious Diseases ·Oliver Stirrup, Madhumita Shrotri, Natalie Adams, Maria Krutikov, (unknown), Borscha Azmi, Tom Palmer, Christopher Fuller, Aidan Irwin-Singer, (unknown), Gokhan Tut, Paul Moss, Andrew Hayward, Andrew Copas, Laura Shallcross	6
3	Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study. 2022 ·Apollo (University of Cambridge) ·Maria Krutikov, Oliver Stirrup, (unknown), Borscha Azmi, Chris Fuller, Gokhan Tut, Tom Palmer, Madhumita Shrotri, Aidan Irwin-Singer, (unknown), Andrew Hayward, Paul Moss, Andrew Copas, Laura Shallcross, (unknown)	29
4	Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study 2022 ·The Lancet Healthy Longevity ·Madhumita Shrotri, Maria Krutikov, (unknown), Borscha Azmi, Tom Palmer, Rebecca Giddings, Christopher Fuller, Aidan Irwin-Singer, (unknown), Gokhan Tut, Paul Moss, Andrew Hayward, Andrew Copas, Laura Shallcross	20
5	Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study 2021 ·The Lancet Infectious Diseases ·Madhumita Shrotri, Maria Krutikov, Tom Palmer, Rebecca Giddings, Borscha Azmi, Sathyavani Subbarao, Christopher Fuller, Aidan Irwin-Singer, Daniel Davies, Gokhan Tut, Jamie Lopez Bernal, Paul Moss, Andrew Hayward, Andrew Copas, Laura Shallcross	120
6	Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study 2021 ·The Lancet Healthy Longevity ·Maria Krutikov, Tom Palmer, Gokhan Tut, Chris Fuller, Madhumita Shrotri, (unknown), Daniel Davies, Aidan Irwin-Singer, James Robson, Andrew Hayward, Paul Moss, Andrew Copas, Laura Shallcross	36
7	Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England 2021 ·The Lancet Healthy Longevity ·Maria Krutikov, Tom Palmer, Gokhan Tut, Christopher Fuller, Borscha Azmi, Rebecca Giddings, Madhumita Shrotri, (unknown), Panagiota Sylla, Tara Lancaster, Aidan Irwin-Singer, Andrew Hayward, Paul Moss, Andrew Copas, Laura Shallcross	65
8	Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021 2021 ·Eurosurveillance ·Rebecca Giddings, Maria Krutikov, Tom Palmer, Christopher Fuller, Borscha Azmi, Madhumita Shrotri, Aidan Irwin-Singer, Gokhan Tut, Paul Moss, Andrew Copas, Laura Shallcross	7
9	Vaccine Effectiveness of the First Dose of ChAdox1 nCOV-19 and BNT162b2 Against SARS-CoV-2 Infection in Residents of Long Term Care Facilities (VIVALDI Study) 2021 ·SSRN Electronic Journal ·Madhumita Shrotri, Maria Krutikov, Tom Palmer, Rebecca Giddings, Borscha Azmi, Sathyavani Subbarao, Christopher Fuller, Aidan Irwin-Singer, Daniel Davies, Gokhan Tut, Jamie Lopez Bernal, (unknown), Andrew Hayward, Andrew Copas, Laura Shallcross	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact